Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Current Deferred Revenue (2023 - 2025)

Historic Current Deferred Revenue for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to $138252.7.

  • Zhengye Biotechnology Holding's Current Deferred Revenue changed N/A to $138252.7 in Q2 2025 from the same period last year, while for Jun 2025 it was $138252.7, marking a year-over-year change of. This contributed to the annual value of $477000.0 for FY2024, which is 2673.4% down from last year.
  • Zhengye Biotechnology Holding's Current Deferred Revenue amounted to $138252.7 in Q2 2025.
  • In the past 5 years, Zhengye Biotechnology Holding's Current Deferred Revenue ranged from a high of $639020.9 in Q4 2023 and a low of $27843.1 during Q4 2024
  • For the 3-year period, Zhengye Biotechnology Holding's Current Deferred Revenue averaged around $268372.3, with its median value being $138252.7 (2025).
  • Data for Zhengye Biotechnology Holding's Current Deferred Revenue shows a peak YoY increase of 9564.28% (in 2024) and a maximum YoY decrease of 9564.28% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Current Deferred Revenue (Quarter) stood at $639020.9 in 2023, then tumbled by 95.64% to $27843.1 in 2024, then surged by 396.54% to $138252.7 in 2025.
  • Its last three reported values are $138252.7 in Q2 2025, $27843.1 for Q4 2024, and $639020.9 during Q4 2023.